Does apple cider vinegar cause meaningful weight or body-fat loss?

The Claim

Regular apple cider vinegar consumption causes clinically meaningful weight or body-fat loss in adults with overweight or obesity.

This investigation is deliberately narrower than “apple cider vinegar is healthy” and stronger than “some studies found a statistically significant difference.”

The question is whether apple cider vinegar (ACV) itself produces a weight or body-fat effect large and reliable enough to matter clinically over weeks or months.

Where It Comes From

Vinegar has a long history as a food and folk remedy. Modern ACV marketing combines that tradition with plausible metabolic mechanisms: acetic acid may influence gastric emptying, post-meal glucose, appetite, lipid metabolism or fat oxidation.

Weight-loss claims accelerated as small clinical trials reported favorable anthropometric outcomes. A 2024 randomized study in Lebanese adolescents and young adults became particularly influential because it reported unusually large reductions.

That paper was later retracted.

Why It Sounds Convincing

The claim is not built from nothing.

A 2009 Japanese randomized double-blind trial found that participants with obesity assigned daily vinegar for 12 weeks lost modestly more weight and visceral fat than placebo participants. Later meta-analyses pooled several trials and reported significant reductions.

ACV also has measurable metabolic effects, especially on post-meal glucose.

Those observations make a small weight effect biologically plausible.

The difficulty is deciding how much of the apparent effect survives once study quality, small samples and the retracted high-effect trial are handled correctly.

The Short Answer

Apple cider vinegar might produce a small amount of short-term weight loss in some settings, but reliable, lasting weight or body-fat loss has not been established.

Several controlled studies report modest differences. Others show little or no weight change, and many are short or combine vinegar with dietary advice or medication.

One unusually dramatic positive trial was retracted in 2025 because its results could not be reliably verified. Reviews that included it need to be interpreted cautiously. The evidence remains Inconclusive, not a demonstrated major weight-loss effect.

How It Would Have to Work

For ACV to cause meaningful weight loss, regular consumption would need to change energy intake, energy expenditure, nutrient handling or body composition enough to produce a reproducible between-group difference.

Possible mechanisms include increased satiety, slower gastric emptying, altered glycemic responses and metabolic effects of acetate.

A mechanism is not the endpoint. The intervention must still produce sustained weight or fat loss in controlled human trials, ideally without unequal co-interventions or major dietary differences between groups.

What Actually Happens

Vinegar contains acetic acid, which can alter the physiological response to meals.

Some participants may also experience nausea or reduced appetite, which could reduce energy intake. If that occurs, a weight difference may be real while the causal pathway is still ordinary calorie reduction rather than a special fat-burning effect.

Small nutrition trials are especially vulnerable to noisy body-weight data, imperfect adherence and unmeasured changes in diet.

That makes replication important.

What the Evidence Shows

Do randomized trials show any weight difference?

A 2009 Japanese study assigned adults to beverages containing different amounts of apple vinegar or no vinegar. After about three months, the vinegar groups had lost somewhat more weight—roughly one to two kilograms on average—while the comparison group had not. The original researchers also measured a modest reduction in abdominal fat, which is a separate relevant outcome. Weight tended to return after treatment stopped. The trial was short and involved researchers employed by a vinegar manufacturer. Its actual tested beverage matters: it is evidence about an apple-vinegar formulation, not every commercial ACV product.

A 2018 study tested apple cider vinegar alongside a calorie-restricted diet. Participants taking vinegar lost somewhat more weight than those following the diet alone. But neither the difference in body-fat mass nor the difference in waist reduction was clearly established. Participants knew whether they were taking vinegar, which can affect behavior and expectations, and both groups were dieting.

Another randomized study in 2023 examined people with type 2 diabetes receiving diet advice. It reported a favorable short-term weight difference when apple cider vinegar was added. However, the study was not blinded, group weights differed at the start, and body fat was not directly measured.

A 2026 placebo-controlled trial in women with polycystic ovary syndrome reported a favorable change in body mass index (BMI) for those receiving apple-cider-vinegar capsules. That is potentially useful evidence, but both groups also took metformin; the participants were a selected clinical population, and BMI is not a direct measure of body fat or lasting weight maintenance.

Are there trials that found no convincing weight benefit?

Yes. One placebo-controlled study in adults with diabetes found little weight change after taking apple cider vinegar. Another clinical comparison also failed to establish a clear added weight-loss benefit when vinegar was combined with diabetes medication.

These studies differ in treatment, follow-up and patient population, so a single negative trial cannot prove that every possible modest effect is absent. Together, they show why an ACV benefit should not be presented as consistent across experiments.

Why did a high-profile study get retracted?

A 2024 trial reporting unusually large benefits was formally retracted by BMJ in September 2025, following problems with the dataset and attempts to reproduce its analysis. Its reported benefits should not be treated as reliable evidence.

An ACV-focused meta-analysis published in 2025 had included that study. Merely removing trials classified by the review as high-risk would not solve the problem, because the subsequently retracted trial was initially rated favorably. The pooled effect therefore needs reanalysis without the withdrawn result.

Researchers also identified other source problems in the ACV literature: one study described in the meta-analysis as apple cider vinegar actually tested a grape-vinegar-and-sugar mixture; another study citation pointed to a different report; and comparisons from a single multi-arm trial shared one placebo group. Those details matter to a defensible pooled estimate, but none by itself invalidates every smaller original positive trial.

What do broader vinegar reviews say?

A separate review of vinegar studies published before the problematic 2024 trial estimated a small average weight difference. A 2026 review of previous reviews also found approximately a kilogram of average benefit for vinegar in general, and its identified weight-study list did not include the retracted trial. That is relevant supporting evidence, not proof that the ACV-specific results have been fully corrected.

The broader reviews combine formulations and overlapping studies, and do not establish durable loss of body fat from ordinary apple cider vinegar.

Bottom line

There is a reasonable case for studying small short-term effects on body weight or BMI. It is still unclear how much is independently caused by ACV, whether actual fat mass decreases, and whether any benefit lasts. That uncertainty matters far more to readers than a catalogue of confidence intervals.

The Strongest Evidence for the Claim

The strongest case rests on several original randomized studies, especially the older Japanese apple-vinegar trial, smaller ACV diet-comparison studies and a newer placebo-controlled BMI finding in women with polycystic ovary syndrome. A broader review of vinegar studies also suggests a modest average effect.

A roughly kilogram-scale short-term difference might be real. But the study populations, formulations and co-treatments differ, and such a result would not demonstrate dramatic or lasting loss of body fat.

The Strongest Evidence Against It

The case for a dependable weight-loss product is weakened by mixed trial results, small studies, short follow-up and inconsistent measurement of actual body fat.

A highly influential positive study was retracted after serious data concerns. A later meta-analysis included it and cannot be read as retraction-adjusted; other reviews address a broader range of vinegar preparations rather than exclusively ACV.

The remaining evidence permits a modest effect but does not securely establish its size, clinical importance or durability.

Common Viral Arguments

“A randomized trial showed huge weight loss with ACV.”

The study most often cited for dramatic recent effects was retracted. A retracted result should not remain in the evidence stack as if nothing happened.

“A meta-analysis proves ACV works.”

Meta-analysis aggregates studies; it does not sterilize bad inputs. When a high-effect study is retracted, the synthesis must be reconsidered.

“ACV lowers blood sugar, therefore it causes fat loss.”

Post-meal glycemic effects are a different outcome. A mechanism or adjacent benefit does not establish clinically meaningful weight loss.

“People feel less hungry after vinegar.”

Appetite changes could be a pathway, but anecdotal satiety is not a body-composition trial.

The Reasoning Error

Cherry-picking occurs when the most dramatic positive trial is retained in popular summaries after its evidentiary status collapses.

Overgeneralization occurs when a possible small average effect is presented as robust or substantial weight loss.

The deeper methodological lesson is that statistical significance and clinical importance are separate questions.

What Would Change Our Conclusion?

Several independent preregistered randomized trials with adequate sample sizes, standardized ACV doses, objective adherence measures, stable co-interventions and body-composition outcomes could resolve the question.

A clean updated meta-analysis excluding retracted or high-risk studies would also materially change confidence.

Evidence Status

Status: Inconclusive
Evidence quality: Low

Some randomized studies suggest a small short-term change in body weight or BMI, while others do not. Evidence for sustained, meaningful body-fat loss is weaker.

The retraction of one striking positive study and problems identifying which interventions were actually tested make pooled claims especially uncertain. That does not erase credible smaller trials or establish that all vinegar has zero effect. It means that a robust ACV-specific weight-loss benefit has not yet been demonstrated.

Evidence & Sources

The evidence trail treats retraction as an evidentiary event, not a footnote. Positive older evidence remains visible, but the synthesis is recalibrated after removal of a major unreliable result.

Corrections & Updates

October 8, 2026 — Evidence update: newly available 2026 blinded ACV-and-metformin placebo trial and original 2020 metformin-adjunct comparison added; synthesis and retraction limitations remain, verdict unchanged.

Last Reviewed

October 8, 2026.